Synlogic Inc. - חוב לטווח קצר של החברה SYBX

Synlogic, Inc. previously implemented automated systems for precision dosing in laboratories. The short-term debt trend demonstrates the current financial burden, where the value of 0.00 describes the current level. Looking ahead, the company plans to monetize bioengineering patents through partnerships with industry behemoths, while simultaneously transitioning to eco-friendly synthesis methods and safe bio-waste disposal to comply with ESG standards.

Short-term debts measure the volume of urgent obligations that require a constant inflow of liquidity to prevent cash gaps and ensure solvency. An analysis of changes in short-term liabilities on GURU.Markets allows for an assessment of the financial stability of Synlogic, Inc. (SYBX), where the transition to intellectual property licensing and digital microbe modeling minimizes capital expenditures, reducing reliance on external borrowings.